ProShare Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $263K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $251K | Buy |
|
|||||
|
2022
Q3 | $383K | Buy |
|
|||||
|
2022
Q2 | $345K | Sell |
|
|||||
|
2022
Q1 | $565K | Sell |
|
|||||
|
2021
Q4 | $1.32M | Sell |
|
|||||
|
2021
Q3 | $2.14M | Buy |
|
|||||
|
2021
Q2 | $1.49M | Sell |
|
|||||
|
2021
Q1 | $3.16M | Buy |
|
|||||
|
2020
Q4 | $3.79M | Buy |
|
|||||
|
2020
Q3 | $1.96M | Sell |
|
|||||
|
2020
Q2 | $1.37M | Buy |
|
|||||
|
2020
Q1 | $551K | Sell |
|
|||||
|
2019
Q4 | $1.57M | Sell |
|
|||||
|
2019
Q3 | $1.07M | Buy |
|
|||||
|
2019
Q2 | $1.32M | Sell |
|
|||||
|
2019
Q1 | $1.05M | Buy |
|
|||||
|
2018
Q4 | $558K | Buy |
|